Patents by Inventor Seeta Rama Anjaneyulu GORANTLA

Seeta Rama Anjaneyulu GORANTLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
    Patent number: 11427570
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: August 30, 2022
    Assignee: Laurus Labs Limited
    Inventors: Satyanarayana Chava, Seeta Rama Anjaneyulu Gorantla, Venkata Sunil Kumar Indukuri, Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Durga Prasad Kuchipudi
  • Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof
    Patent number: 11299477
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: April 12, 2022
    Assignee: Laurus Labs Limited
    Inventors: Satyanarayana Chava, Seeta Rama Anjaneyulu Gorantla, Venkata Sunil Kumar Indukuri, Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Durga Prasad Kuchipudi
  • Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
    Patent number: 10800809
    Abstract: The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 13, 2020
    Assignee: Laurus Labs Limited
    Inventors: Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Srinivasa Rao Buddepu, Lakshmi Kanth Kola, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20200262821
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: February 26, 2020
    Publication date: August 20, 2020
    Inventors: Satyanarayana CHAVA, Seeta Rama Anjaneyulu GORANTLA, Venkata Sunil Kumar INDUKURI, Sanjay Kumar DEHURY, Nagaraju MEKALA, Jahangeer Baba SHAIK, Durga Prasad KUCHIPUDI
  • PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20200262820
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
    Type: Application
    Filed: February 26, 2020
    Publication date: August 20, 2020
    Inventors: Satyanarayana CHAVA, Seeta Rama Anjaneyulu GORANTLA, Venkata Sunil Kumar INDUKURI, Sanjay Kumar DEHURY, Nagaraju MEKALA, Jahangeer Baba SHAIK, Durga Prasad KUCHIPUDI
  • Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
    Patent number: 10730859
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: August 4, 2020
    Assignee: Laurus Labs Limited
    Inventors: Satyanarayana Chava, Seeta Rama Anjaneyulu Gorantla, Venkata Sunil Kumar Indukuri, Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Durga Prasad Kuchipudi
  • Process for the preparation of enzalutamide
    Patent number: 10626091
    Abstract: The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: April 21, 2020
    Assignee: Laurus Labs Limited
    Inventors: Kameswar Rao Chivukula, Veera Venkateswara Rao Karuturi, Srinivas Benda, Ramachandra Anke, Dharmapuri Gajula, Venkata Rama Krishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20190284231
    Abstract: The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
    Type: Application
    Filed: June 6, 2019
    Publication date: September 19, 2019
    Inventors: Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Srinivasa Rao Buddepu, Lakshmi Kanth Kola, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
    Patent number: 10364269
    Abstract: The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
    Type: Grant
    Filed: May 21, 2016
    Date of Patent: July 30, 2019
    Assignee: LAURUS LABS LIMITED
    Inventors: Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Srinivasa Rao Buddepu, Lakshmi Kanth Kola, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
    Patent number: 10301321
    Abstract: The present invention relates to a novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof using novel intermediates.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: May 28, 2019
    Assignee: LAURUS LABS LIMITED
    Inventors: Satyanarayana Chava, Seeta Rama Anjaneyulu Gorantla, Venkata Lakshmi Narasimha Dammalapati, Mani Bushan Kotala, Ravindra Aduri
  • PROCESS FOR THE PREPARATION OF ENZALUTAMIDE
    Publication number: 20190127332
    Abstract: The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.
    Type: Application
    Filed: September 18, 2018
    Publication date: May 2, 2019
    Inventors: Kameswar Rao Chivukula, Veera Venkateswara Rao Karuturi, Srinivas Benda, Ramachandra Anke, Dharmapuri Gajula, Venkata Rama Krishna Murthy Moturu, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20190085026
    Abstract: The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of amorphous form of carfilzomib.
    Type: Application
    Filed: May 21, 2016
    Publication date: March 21, 2019
    Inventors: Sanjay Kumar Dehury, Nagaraju Mekala, Jahangeer Baba Shaik, Srinivasa Rao Buddepu, Lakshmi Kanth Kola, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • NOVEL PROCESS FOR THE PREPARATION OF DOLUTEGRAVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20180155364
    Abstract: The present invention relates to a novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof using novel intermediates.
    Type: Application
    Filed: November 10, 2017
    Publication date: June 7, 2018
    Inventors: Satyanarayana CHAVA, Seeta Rama Anjaneyulu GORANTLA, Venkata Lakshmi Narasimha DAMMALAPATI, Mani Bushan KOTALA, Ravindra ADURI
  • Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereof
    Patent number: 9957234
    Abstract: The present invention relates to novel polymorphic forms of ivacaftor, process for its preparation and pharmaceutical compositions comprising the same.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: May 1, 2018
    Assignee: Laurus Labs Limited
    Inventors: Ram Thaimattam, Venkata Srinivasa Rao Dama, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
    Patent number: 9856271
    Abstract: The present invention relates to a novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof using novel intermediates.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: January 2, 2018
    Assignee: LAURUS LABS LIMITED
    Inventors: Satyanarayana Chava, Seeta Rama Anjaneyulu Gorantla, Venkata Lakshmi Narasimha Dammalapati, Mani Bushan Kotala, Ravindra Aduri
  • NOVEL POLYMORPHS OF IVACAFTOR, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF
    Publication number: 20170334860
    Abstract: The present invention relates to novel polymorphic forms of ivacaftor, process for its preparation and pharmaceutical compositions comprising the same.
    Type: Application
    Filed: December 9, 2015
    Publication date: November 23, 2017
    Inventors: Ram THAIMATTAM, Venkata Srinivasa Rao DAMA, Venkata Sunil Kumar INDUKURI, Seeta Rama Anjaneyulu GORANTLA, Satyanarayana CHAVA
  • AN IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE
    Publication number: 20170313662
    Abstract: The present invention relates to an improved process for the preparation of enzalutamide by conventional synthesis, which avoids utilization of microwave irradiation and noxious reagents. The present invention also relates to an improved process for preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which is an intermediate in the synthesis of Enzalutamide.
    Type: Application
    Filed: October 1, 2015
    Publication date: November 2, 2017
    Inventors: Kameswar Rao Chivukula, Veera Karuturi, Rao Venkateswara, Srinivas Benda, Ramachandra Anke, Dharmapuri Gajula, Venkata Rama Krishna Murt Moturu, Venkata Sunil Kumar Indukuri, Seeta Rama Anjaneyulu Gorantla, Satyanarayana Chava
  • NOVEL PROCESS FOR THE PREPARATION OF DOLUTEGRAVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20160333026
    Abstract: The present invention relates to a novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof using novel intermediates.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 17, 2016
    Applicant: Laurus Labs Private Limited
    Inventors: Satyanarayana CHAVA, Seeta Rama Anjaneyulu GORANTLA, Venkata Lakshmi Narasimha DAMMALAPATI, Mani Bushan Kotala, Ravindra ADURI
  • AN IMPROVED PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20160280689
    Abstract: The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof.
    Type: Application
    Filed: November 5, 2014
    Publication date: September 29, 2016
    Inventors: Satyanarayana CHAVA, Seeta Rama Anjaneyulu GORANTLA, Venkata Sunil Kumar INDUKURI, Sanjay Kumar DEHURY, Nagaraju MEKALA, Jahangeer Baba SHAIK, Durga Prasad KUCHIPUDI